Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolperisone in Acute Low Back Pain (BETA)
NCT05544656Phase 3Active, not recruiting
- Sponsor
- Semmelweis University
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolperisone in acute low back pain, sponsored by Semmelweis University. Started Dec 2019; status: active, not recruiting.
02
Drugs
tolperisone
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT05544656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05544656.